David Charles BoettigerStephen KerrRossana DitangcoTuti Parwati MeratiThuy Thi Thanh PhamRomanee ChaiwarithSasisopin KiertiburanakulChung Ki Patrick LiNagalingeswaran KumarasamySaphonn VonthanakChristopher LeeNguyen Van KinhSanjay PujariWing Wai WongAdeeba KamarulzamanFujie ZhangEvy YunihastutiJun Yong ChoiShinichi OkaOon Tek NgPacharee KantipongMahiran MustafaWinai RatanasuwanAnnette SohnMatthew LawUniversity of New South Wales (UNSW) AustraliaThe HIV Netherlands Australia Thailand Research CollaborationGokilaUniversitas UdayanaBach Mai HospitalResearch Institute for Health SciencesMahidol UniversityQueen Elizabeth Hospital Hong KongYR Gaitonde Centre for AIDS Research and EducationNational Center for HIV/AIDSHospital Sungai BulohNational Hospital of Tropical DiseasesInstitute of Infectious DiseasesVeterans General Hospital-TaipeiUniversity of MalayaBeijing Ditan HospitalUniversitas IndonesiaYonsei UniversityNational Center for Global Health and MedicineTan Tock Seng HospitalChiangrai Prachanukroh HospitalHospital Raja Perempuan Zainab IIFoundation for AIDS Research2018-11-092018-11-092014-09-10PLoS ONE. Vol.9, No.9 (2014)193262032-s2.0-84906982770https://repository.li.mahidol.ac.th/handle/20.500.14594/32987Background: Antiretroviral therapy (ART) has evolved rapidly since its beginnings. This analysis describes trends in first-line ART use in Asia and their impact on treatment outcomes.Mahidol UniversityAgricultural and Biological SciencesBiochemistry, Genetics and Molecular BiologyArticleSCOPUS10.1371/journal.pone.0106525